XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 54 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $46,000 | +109.1% | 10,236 | -6.2% | 0.00% | – |
| Q1 2020 | $22,000 | -29.0% | 10,912 | +251.4% | 0.00% | – |
| Q3 2019 | $31,000 | -11.4% | 3,105 | -10.1% | 0.00% | – |
| Q1 2019 | $35,000 | -40.7% | 3,454 | 0.0% | 0.00% | – |
| Q4 2018 | $59,000 | -3.3% | 3,454 | 0.0% | 0.00% | – |
| Q3 2018 | $61,000 | +7.0% | 3,454 | +15.1% | 0.00% | – |
| Q2 2018 | $57,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |